Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of phenyl trifluoromethanesulfonate imine via acid catalysis. Offers high purity for liquid crystal materials and organic synthesis intermediates with simplified processing.
Novel Zn-catalyzed synthesis offers high yield and easy separation for acenaphthyl α-diimine ligands, ensuring reliable supply chain for polymerization catalysts.
Novel method for chiral 3-fluoro-2-indolone derivatives via Ellman imine addition. High yield, mild conditions, scalable for API intermediates.
Novel Pd-catalyzed cyclization of 2,3-allenamides offers high regioselectivity and yield for pharmaceutical intermediates, ensuring cost-effective supply chain solutions.
Patent CN105061278A reveals high-yield imine synthesis using copper catalysis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel iron-catalyzed oxidation process ensures high purity and scalable supply for agrochemical and pharmaceutical intermediates. This technology significantly reduces production costs while enhancing supply chain reliability for global buyers seeking reliable pharmaceutical intermediates supplier partners.
Novel electrolyte-free method for alpha-ketoamides using sulfoximines. Reduces metal waste and simplifies purification for reliable supply chains.
Novel Pt-Sn catalyst method for imine preparation offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners globally.
Discover the novel copper-catalyzed synthesis of N-sulfonyl imine coumarins. High purity, mild conditions, and scalable routes for API intermediates.
Patent CN103694157A reveals a mild, high-yield route for chiral alpha-chloroaziridines. Discover cost-effective manufacturing solutions for complex nitrogen heterocycles.
Patent CN118909993A reveals a high-activity imine reductase mutant for green synthesis. Achieves >99% optical purity and high space-time yield for reliable supply.
Patent CN106608776A details nickel-catalyzed imine synthesis offering high purity and atom economy. This method ensures cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN108623494B details a green photocatalytic method for synthesizing imines using sulfur-containing aza metalloporphyrin, offering high selectivity and cost reduction.
Novel synthesis route for tetrafluorobenzyl-5-aminosalicylic acid salts avoiding dimer impurities. Enhanced stability and scalability for pharmaceutical manufacturing.
Novel symmetrical synthesis method reduces costs and improves supply chain reliability for high purity intermediate manufacturing globally ensuring consistent quality and scalable production capabilities for international buyers.
Patent CN112852771A details enzymatic synthesis of chiral amino alcohols using imine reductase, offering high stereoselectivity and mild conditions for pharmaceutical manufacturing.
Advanced racemization technology for ortho-substituted 1-phenylethylamine derivatives enables efficient recycling of unwanted enantiomers in agrochemical manufacturing.
Patent CN115404249A reveals a novel enzymatic route for (S)-nicotine intermediates. Discover cost-effective biocatalysis solutions for scalable pharmaceutical manufacturing.
Patent CN107304176A details a mild chiral synthesis route for alpha-fluoro beta-amino acids, offering high optical purity and scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed route for 4-pentene sulfoximine amidines. High efficiency, room temp, scalable for pharma intermediates.